Topical treatment for burn pain by blocking cutaneous pain receptors.

Project Summary (Abstract)
Title: Technical and Business Assistance for Commercialization of Topical Treatment
for Burn Pain
This TABA request supports critical commercialization activities for the Phase I SBIR
project. The project focuses on the development of a first-in-class, non-opioid topical
formulation targeting TRPV1 and related cutaneous pain receptors, offering a novel
therapeutic approach for managing burn pain.
This support will directly enhance our readiness for Phase II funding and facilitate
downstream partnering or licensing opportunities. The proposed assistance is essential
to translating our research into a viable therapeutic product that addresses the
significant unmet need in treating burn-related pain.

Grant Number: 3R43GM150295-01A1S1
NIH Institute/Center: NIH
Principal Investigator: Kumaril Bhargava